Guidance         for   Industry
Distributing Scientific and Medical
Publications on Risk Information for
Approved   Prescription Drugs and
Biological Productsâ€”Recommended
Practices
Comments and suggestions regarding this draft document should be submitted within 75 days of
publication in the Federal Register of the notice announcing the availability of the draft guidance.
Submit electronic comments to http://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
All comments should be identified with the docket number listed in the notice of availability that
publishes in the Federal Register.
